Completed

Estrogen Effects on Cognition in Girls With Turner Syndrome

0 criteria met from your profileSee at a glance how your profile meets each eligibility criteria.
What is being tested

cognitive tests and scales

Behavioral
Who is being recruted

Congenital Abnormalities+17

+ Urogenital Diseases

+ Cardiovascular Diseases

See all eligibility criteria
How is the trial designed

Treatment Study

Phase 2
Interventional
Study Start: May 1990
See protocol details

Summary

Principal SponsorEunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Last updated: March 4, 2008
Sourced from a government-validated database.Claim as a partner

Study start date: May 1, 1990

Actual date on which the first participant was enrolled.

Estrogen influences brain development in females at puberty. Environmental and cultural factors interact with the biological effects of estrogen on the brain and consequently on cognition and behavior. Turner syndrome females lack endogenous estrogen as a result of dysgenetic ovaries. Turner syndrome therefore represents a unique, estrogen-deficient model in which to study the biological effects of estrogen on cognition and behavior. The specific aims of this project are to: 1) document further, the cognitive differences between girls with Turner syndrome at ages 5 to adult (less than or equal to age 50) versus age-matched, female controls. 2) to examine the differential effects of continuous estrogen replacement in infancy and in early childhood on cognitive and social function in a unique, previously approved, randomized, double-blind, placebo-controlled, treatment trial (87-CH-0152). Specifically, we hypothesize that estrogen replacement in early childhood will reduce the cognitive deficits of girls with Turner syndrome. In addition, we hypothesize that the degree of socialization ability in these girls will correlate with social-behavioral and social recognition ability. Finally, we hypothesize that earlier (infancy to 8 years) and longer estrogen replacement will result in less impairment of visual-motor ability, visual-spatial ability, socialization ability, and affective competence compared to later (9 to 12 years) estrogen replacement in girls with Turner syndrome. Children with Turner syndrome and controls will be tested in the Outpatient Departments at the two approved sites of protocol 87-CH-0152; the NIH and Thomas Jefferson University.

NCT00001253
Principal SponsorEunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Last updated: March 4, 2008
Sourced from a government-validated database.Claim as a partner

Protocol

This section provides details of the study plan, including how the study is designed and what the study is measuring.
Design Details

950 patients to be enrolled

Total number of participants that the clinical trial aims to recruit.

Treatment Study

These studies test new ways to treat a disease, condition, or health issue. The goal is to see if a new drug, therapy, or approach works better or has fewer side effects than existing options.

Eligibility

Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.
Conditions
Criteria

Any sex

Biological sex of participants that are eligible to enroll.

Healthy volunteers allowed

If individuals who are healthy and do not have the condition being studied can participate.

Conditions

Pathology

Congenital AbnormalitiesUrogenital DiseasesCardiovascular DiseasesEndocrine System DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsGonadal DisordersHeart Defects, CongenitalHeart DiseasesCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesDisorders of Sex DevelopmentUrogenital AbnormalitiesCardiovascular AbnormalitiesChromosome DisordersSex Chromosome DisordersGenetic Diseases, InbornFemale Urogenital DiseasesMale Urogenital DiseasesSex Chromosome Disorders of Sex DevelopmentGonadal DysgenesisTurner Syndrome

Criteria

INCLUSION CRITERIA: Patients will include girls and women ages 5-50 yr with the diagnosis of Turner syndrome based on absence of all or part of one of the X chromosomes. Control subjects must be within +/- 2SD for height and weight and have normal intelligence and educational achievement. Biological parents (both male and female) of TS subjects may be included in this study, but only to have blood drawn for genetic testing in order to determine the origin of the X-chromosome of their daughters. EXCLUSION CRITERIA: Those with severe physical or neurocognitive impairment, preventing accurate completion of the cognitive tasks, will be excluded. Normal subjects who have qualified for or participated in gifted and talented or remedial education programs.

Study Centers

These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.

This study has 1 location

National Institute of Child Health and Human Development (NICHD)

Bethesda, United StatesOpen National Institute of Child Health and Human Development (NICHD) in Google Maps
CompletedOne Study Center